Revenue: The sum of all revenue fields included for a company's operating activities.
Syndax Pharmaceuticals, Inc. (SNDX) had Revenue of $83.30M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$83.30M |
$-49.43M |
|
$14.00M |
|
$69.30M |
|
$125.19M |
|
$-41.90M |
|
$-7.54M |
|
$-49.43M |
|
$-49.43M |
|
$-49.43M |
|
$-49.43M |
|
$-49.43M |
|
$-49.43M |
|
$-41.90M |
|
$-43.30M |
|
89.79M |
|
89.79M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$567.44M |
|
$0.21M |
|
$125.23M |
|
$692.67M |
|
$120.96M |
|
$588.28M |
|
$588.89M |
|
$709.85M |
|
$-17.18M |
|
$-17.18M |
|
$-17.18M |
|
89.99M |
|
| Cash Flow Statement Financials | |
$-107.87M |
|
$-155.00M |
|
$263.88M |
|
$135.03M |
|
$136.04M |
|
$1.01M |
|
$41.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.69 |
|
-- |
|
-- |
|
1.03 |
|
-34.24 |
|
83.20% |
|
-50.30% |
|
-50.30% |
|
-- |
|
-59.34% |
|
-59.34% |
|
$-107.91M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.36 |
|
1.09 |
|
82.89 |
|
287.74% |
|
287.74% |
|
-7.14% |
|
-8.66% |
|
$-0.19 |
|
$-1.20 |
|
$-1.20 |
|